PH11722A - 1-teritiary alkyl-3-substituted phenyl(or thietyl)ureas,pharmaceutical compositions containing same and method of treating hypertension - Google Patents

1-teritiary alkyl-3-substituted phenyl(or thietyl)ureas,pharmaceutical compositions containing same and method of treating hypertension

Info

Publication number
PH11722A
PH11722A PH17061A PH17061A PH11722A PH 11722 A PH11722 A PH 11722A PH 17061 A PH17061 A PH 17061A PH 17061 A PH17061 A PH 17061A PH 11722 A PH11722 A PH 11722A
Authority
PH
Philippines
Prior art keywords
teritiary
thietyl
ureas
alkyl
pharmaceutical compositions
Prior art date
Application number
PH17061A
Other languages
English (en)
Inventor
G Berezin
P Aldrich
B Ditimar
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of PH11722A publication Critical patent/PH11722A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D331/00—Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
    • C07D331/04—Four-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/46—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
    • C07D333/48—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH17061A 1974-04-17 1975-04-16 1-teritiary alkyl-3-substituted phenyl(or thietyl)ureas,pharmaceutical compositions containing same and method of treating hypertension PH11722A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46169974A 1974-04-17 1974-04-17
US05/555,307 US4009847A (en) 1974-04-17 1975-03-11 1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents

Publications (1)

Publication Number Publication Date
PH11722A true PH11722A (en) 1978-05-30

Family

ID=27040095

Family Applications (1)

Application Number Title Priority Date Filing Date
PH17061A PH11722A (en) 1974-04-17 1975-04-16 1-teritiary alkyl-3-substituted phenyl(or thietyl)ureas,pharmaceutical compositions containing same and method of treating hypertension

Country Status (21)

Country Link
US (1) US4009847A (is")
JP (1) JPS50148349A (is")
AR (1) AR208545A1 (is")
CA (1) CA1047042A (is")
CH (1) CH611292A5 (is")
DD (1) DD117223A5 (is")
DE (1) DE2516554A1 (is")
DK (1) DK164175A (is")
ES (1) ES436648A1 (is")
FI (1) FI751128A7 (is")
FR (1) FR2267773B1 (is")
GB (1) GB1461209A (is")
HU (1) HU173052B (is")
IE (1) IE41143B1 (is")
IL (1) IL47095A (is")
LU (1) LU72306A1 (is")
NL (1) NL7504570A (is")
NO (1) NO144071C (is")
PH (1) PH11722A (is")
SE (1) SE417965B (is")
YU (1) YU96075A (is")

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156738A (en) * 1977-10-07 1979-05-29 E. I. Du Pont De Nemours And Company Ureidonitriles useful as antihypertensives
US6187799B1 (en) * 1997-05-23 2001-02-13 Onyx Pharmaceuticals Inhibition of raf kinase activity using aryl ureas
US6344476B1 (en) 1997-05-23 2002-02-05 Bayer Corporation Inhibition of p38 kinase activity by aryl ureas
US7329670B1 (en) * 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US7517880B2 (en) 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US20080300281A1 (en) * 1997-12-22 2008-12-04 Jacques Dumas Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
US20080269265A1 (en) * 1998-12-22 2008-10-30 Scott Miller Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
US8124630B2 (en) * 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
HK1042251B (en) * 1999-01-13 2012-07-20 Bayer Healthcare Llc Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
US7351834B1 (en) 1999-01-13 2008-04-01 Bayer Pharmaceuticals Corporation ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
WO2000042012A1 (en) 1999-01-13 2000-07-20 Bayer Corporation φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) * 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
RS52500B (en) * 2001-12-03 2013-04-30 Bayer Healthcare Llc Aryl of urea compounds in combination with other cytostatic or cytotoxic agents for the treatment of human cancers
US20080108672A1 (en) * 2002-01-11 2008-05-08 Bernd Riedl Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
WO2003068229A1 (en) * 2002-02-11 2003-08-21 Bayer Pharmaceuticals Corporation Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
AU2003210969A1 (en) * 2002-02-11 2003-09-04 Bayer Corporation Aryl ureas with raf kinase and angiogenesis inhibiting activity
WO2003068746A1 (en) * 2002-02-11 2003-08-21 Bayer Pharmaceuticals Corporation Aryl ureas as kinase inhibitors
ES2425739T3 (es) * 2002-02-11 2013-10-17 Bayer Healthcare Llc Sorafenib-tosilato para el tratamiento de enfermedades caracterizadas por angiogénesis anormal
US7557129B2 (en) 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
PL1626714T3 (pl) * 2003-05-20 2007-12-31 Bayer Healthcare Llc Diarylowe pochodne mocznika do schorzeń, w których pośredniczy PDGFR
NZ580384A (en) * 2003-07-23 2011-03-31 Bayer Pharmaceuticals Corp 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide and metabolites for the treatment and prevention of diseases and conditions
US7838524B2 (en) * 2004-04-30 2010-11-23 Bayer Healthcare Llc Substituted pyrazolyl urea derivatives useful in the treatment of cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH452475A (de) * 1965-05-20 1968-05-31 Bayer Ag Verfahren zum Färben und Bedrucken von synthetischem Textilmaterial mit Anthrachinonfarbstoffen

Also Published As

Publication number Publication date
FR2267773B1 (is") 1978-08-18
NO144071C (no) 1981-06-17
FR2267773A1 (is") 1975-11-14
NO144071B (no) 1981-03-09
YU96075A (en) 1983-04-27
US4009847A (en) 1977-03-01
JPS50148349A (is") 1975-11-27
HU173052B (hu) 1979-02-28
IE41143L (en) 1975-10-17
CH611292A5 (is") 1979-05-31
SE417965B (sv) 1981-04-27
SE7503523L (sv) 1975-10-20
LU72306A1 (is") 1976-03-17
ES436648A1 (es) 1977-08-01
AU8013575A (en) 1976-10-21
IL47095A (en) 1978-03-10
NO751351L (is") 1975-10-20
GB1461209A (en) 1977-01-13
DD117223A5 (is") 1976-01-05
FI751128A7 (is") 1975-10-18
NL7504570A (nl) 1975-10-21
IL47095A0 (en) 1975-06-25
CA1047042A (en) 1979-01-23
AR208545A1 (es) 1977-02-15
DE2516554A1 (de) 1975-10-30
DK164175A (da) 1975-10-18
IE41143B1 (en) 1979-10-24

Similar Documents

Publication Publication Date Title
PH11722A (en) 1-teritiary alkyl-3-substituted phenyl(or thietyl)ureas,pharmaceutical compositions containing same and method of treating hypertension
PH13553A (en) Pharmaceutical compositions containing 2,6 diisopropylphenol and method of use thereof
PH10476A (en) Hexahydro-dibenzo(b,d)pyran-9-ones,compositions containing them and method of use
ZA757481B (en) New antihypertensive compounds and method of preparing same
IL47625A (en) 4-heterocyclyl-6,7-dialkoxyquin-azoline derivatives and pharmaceutical compositions containing them
IL46695A (en) Substituted n-(1-benzylpyrrolidinyl-2-alkyl)-benzamides, their preparation and pharmaceutical compositions containing them
IL47269A0 (en) New phenylguanidine derivatives,their preparation and pharmaceutical compositions containing them
PH11250A (en) (-aryl-4)substituted piperidinoalkanol derivatives,composition and method of use thereof
NZ178313A (en) Certain amines, and pharmaceutical compositions containingthem
IL47015A (en) Derivatives of phenthylamino-ketones and phenthylamino-dioxolanes,their preparation and pharmaceutical compositions containing them
KE2900A (en) N-(1-benzylpiperid-4-yl)-benzamides, methods for their preparation and pharmaceutical compositions containing them
IL47149A0 (en) New amino acid derivatives,their preparation and pharmaceutical compositions containing them
IL47404A0 (en) Pyrazolobenzazepines,their manufacture and pharmaceutical compositions containing them
NZ179599A (en) Xanthine derivatives, and pharmaceutical compositions containing such
PH14398A (en) Pharmaceutical compounds,compositions containing same and method of use
IL46725A (en) 4-o(2',6'-diamino-2',3',4',6'-tetra-desoxy-alpha d-erythrohexopyrannosyl)6-o-3"-methylamino-3",4",6"-tridesoxy alpha d-xylohexopyrannosyl)-2-desoxystreptamine and its salts and process of preparation and pharmaceutical compositions
ZA752863B (en) Active derivatives of methylemaine, therapeutic compositions containing the same and processes for preparing the said derivatives and compositions
IL48617A0 (en) 11-desoxy-15-substituted-omega-pentanorprostaglandins and pharmaceutical compositions containing them
IL47761A (en) 9-hydroxy-19,20-bis-nor-prostanic acid and derivatives andpharmaceutical compositions containing them
NZ179530A (en) 9-aminoalk(en)yl-9,10-dihydro9,10-methanoanthracenes and pharmaceutical compositions
GB1487007A (en) Nitrofuran hydrazones processes for their preparation and pharmaceutical compositions
IL48147A (en) Pharmaceutical compositions containing substituted tetrahydrofuro(3-4-b)furan2,4-diones and some novel compounds of this type
PH11869A (en) 1-tertiary alkyl-or l-cycloakyl-3*(substituted cyclohexenyl)ureas,pharmaceutical compositions containing same and method of treatment thereof
IL46707A0 (en) Phenylbutanol derivatives,process for their preparation and compositions containing them
IL48527A0 (en) New 7,7-diphenyl-hexahydro-1,4-oxazepines,their manufacture and pharmaceutical compositions containing them